Health Condition 1: C61- Malignant neoplasm of prostate
Conditions
Interventions
Intervention1: Nil: Nil
Sponsors
Mahamana Pandit Madan Mohan Malaviya Cancer Centre (MPMMCC)
Eligibility
Inclusion criteria
Inclusion criteria: 1.Male gender aged 18 years or above 2.Histologically confirmed diagnosis of adenocarcinoma of the prostate at any stage 3.Currently receiving active treatment by any modality or on follow up after primary treatment 4.Able to understand the study information and provide written informed consent in a locally understood language 5.Able to complete the questionnaire independently or with minimal non leading assistance from a trained study coordinator or caregiver
Exclusion criteria
Exclusion criteria: 1.Any cognitive impairment or psychiatric condition that, in the opinion of the treating physician, would preclude meaningful participation in the survey. 2.Patients who are critically ill or hospitalized in an unstable condition at the time of approach.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary ObjectiveTo evaluate patient-reported experiences, symptom burden, health-related quality of life (HRQoL), factors influencing treatment decision-making, and perceived gaps in care delivery among men diagnosed with prostate cancer in India.Timepoint: 2 years | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.To identify and quantify delays in the diagnostic pathway and treatment initiation. 2.To characterize patient-reported toxicities associated with different treatment modalities (e.g., surgery, radiation, ADT, novel hormonal agents, chemotherapy). 3.To assess the prevalence and severity of financial toxicity and the associated travel burden. 4.To evaluate psychological health (anxiety and depression) and sexual health concerns. 5.To assess patient awareness and perceptions regarding clinical trials, advanced diagnostics (e.g. PSMA PET) and novel treatments. 6.To measure digital health readiness, including comfort with technology and acceptance of telemedicine. 7.To identify key unmet needs and patient priorities to inform national clinical practice guidelines and patient support programs. Timepoint: 2 years | — |
Countries
India
Contacts
Public ContactDr Arpita Singh
Mahamana Pandit Madanmohan Malviya Cancer Centre (MPMMCC)
Outcome results
None listed